Outcome of treatment of 160 patients with squamous cell carcinoma of the neck staged N3a
β Scribed by Dr. John H. Isaacs Jr.; J. R. Schnitman
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 422 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
One hundred sixty patients with N3a neck disease were studied to evaluate the overall treatment outcome. Of these, 54 recieved palliative radiotherapy and 106 patients were treated with treated with curative intent. Twenty patients (19%) died of interβcurrent disease (13 at less than 2 years), and 13 of 93 patients followed for 2 or more years are alive with no evidence of disease. Thus, 73 patients died directly from cancer, with metaβstatic disease being the leading cause of death. Almost one third of the patients failed to complete treatment.
π SIMILAR VOLUMES
## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the
## Abstract ## Objectives: This study evaluates the oncologic outcome with regard to survival and locoregional tumor control in a cohort of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated according to a uniform algorithm. ## Study Design: Retrospective chart review. ## Metho
Objectives/Hypothesis: Although treatment paradigms have shifted to recommend primary chemoradiation therapy (CRT) for advanced head and neck squamous cell carcinoma, few studies include any significant number of patients with N3 (>6 cm) neck disease. The objective of this study was to determine if
Background. Comorbid conditions have a significant impact on the actuarial survival of patients with head and neck cancer. However, no studies have evaluated the impact of comorbidity on tumor-and treatment-specific outcomes. This study was performed to evaluate the impact of comorbidity, graded by
## Abstract ## Background A prospective study was undertaken to evaluate a policy of selective, singleβmodality elective neck treatment in T1β2, nodeβnegative oral tongue squamous cell carcinoma. ## Methods Where the primary tumor showed 1 of the 4 key pathological criteria (greater than 7 mm of